»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
ºñ¾Ï¼º ÇǺΠÁúȯ Ä¡·áÁ¦ ½ÃÀåÀº 2024-2029³â¿¡ 314¾ï 6,490¸¸ ´Þ·¯, ¿¹Ãø ±â°£ Áß CAGRÀº 11.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ºñ¾Ï¼º ÇǺΠÁúȯ Ä¡·áÁ¦ ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.
ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº ÇǺΠÁúȯÀÇ ³ôÀº À¯º´·ü, ½ÃÀå »óȲÀÇ °·ÂÇÑ ÆÄÀÌÇÁ¶óÀÎ, °³ÀÎÈ ¼ö¿ä Áõ°¡ µîÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ¿¬µµ
2025³â
Á¾·á¿¬µµ
2029³â
¿¹Ãø ±â°£
2025-2029³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â´ëºñ 2025³â
9.5%
CAGR
11.1%
Áõ°¡¾×
314¾ï 6,490¸¸ ´Þ·¯
ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ª ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ¸¶ÀÌÅ©·Î¹ÙÀ̿Ȱú ÇǺΠÀ庮¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö´Â °ÍÀÌ ÇâÈÄ ¼ö³â°£ ºñ¾Ï¼º ÇǺÎÁúȯ Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ÀÌÀ¯ Áß Çϳª·Î ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ ÇǺΠÁúȯÀÇ ¿ÀÁø ¹× ÀÇ·áºñ ÁöÃâ Áõ°¡´Â ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå Technavioº° ºÐ¼®
°¡°Ý¡¤¼ö¸íÁֱ⡤°í°´ ±¸ÀÔ ¹Ù½ºÄÏ¡¤Ã¤Å÷ü¡¤±¸ÀÔ ±âÁØÀÇ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°ÈÀÇ ¿äÀÎ
È¥¶õÀÇ ¿äÀÎ
ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå ±¸µµ
½ÃÀå ¿¡ÄڽýºÅÛ
½ÃÀåÀÇ Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2024³â
½ÃÀå Àü¸Á 2024-2029³â
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ ºñ¾Ï¼º ÇǺΠÁúȯ Ä¡·áÁ¦ ½ÃÀå 2019-2023³â
Ä¡·á ¿µ¿ªº° ºÎ¹® ºÐ¼® 2019-2023³â
Åõ¿© °æ·Îº° ºÎ¹® ºÐ¼® 2019-2023³â
ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® ºÐ¼® 2019-2023³â
Áö¿ªº° ºÎ¹® ºÐ¼® 2019-2023³â
±¹°¡º° ºÎ¹® ºÐ¼® 2019-2023³â
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ : ¼¼°èÀÇ ºñ¾Ï¼º ÇǺΠÁúȯ Ä¡·áÁ¦ ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀïÀÇ À§Çù
½ÃÀå ÇöȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : Ä¡·á ¿µ¿ªº°
½ÃÀå ºÎ¹®
ºñ±³ : Ä¡·á ¿µ¿ªº°
°Ç¼± : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÀÁø : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½É»ó¼º ¿©µå¸§ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : Ä¡·á ¿µ¿ªº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : Åõ¿© °æ·Îº°
½ÃÀå ºÎ¹®
ºñ±³ : Åõ¿© °æ·Îº°
ÁÖ»ç : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
°æ±¸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
±¹¼Ò : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : Åõ¿© °æ·Îº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ºÎ¹®
ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
º´¿ø : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÇǺΰú Ŭ¸®´Ð : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ȨÄɾî : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦11Àå °í°´ »óȲ
Á¦12Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¼¼°èÀÇ ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Çѱ¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
³²¾ÆÇÁ¸®Ä«°øÈ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦13Àå ÃËÁø¿äÀΡ¤°úÁ¦¡¤±âȸ¡¤¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀåÀÇ ±âȸ¡¤¾ïÁ¦¿äÀÎ
Á¦14Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°èÀÇ ¸®½ºÅ©
Á¦15Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
AbbVie Inc.
Amgen Inc.
AstraZeneca Plc
Bayer AG
Bristol Myers Squibb Co.
Eli Lilly and Co.
F. Hoffmann La Roche Ltd.
Galderma SA
GlaxoSmithKline Plc
LEO Pharma AS
Merck KGaA
Novartis AG
Pfizer Inc.
Sanofi SA
Sun Pharmaceutical Industries Ltd.
Á¦16Àå ºÎ·Ï
KSA
The non-cancerous skin diseases therapeutics market is forecasted to grow by USD 31464.9 million during 2024-2029, accelerating at a CAGR of 11.1% during the forecast period. The report on the non-cancerous skin diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of skin diseases, strong pipeline landscape in non-cancerous skin diseases therapeutics, and growing demand for personalized non-cancerous skin diseases therapeutics.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 9.5%
CAGR 11.1%
Incremental Value $31464.9 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's non-cancerous skin diseases therapeutics market is segmented as below:
By Therapy Area
Psoriasis
Eczema
Acne vulgaris
Others
By Route Of Administration
By End-user
Hospitals
Dermatology Clinics
Homecare
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the increased focus on microbiome and skin barrier as one of the prime reasons driving the non-cancerous skin diseases therapeutics market growth during the next few years. Also, misdiagnosis of skin diseases and increasing healthcare expenditure will lead to sizable demand in the market.
The report on the non-cancerous skin diseases therapeutics market covers the following areas:
Non-Cancerous Skin Diseases Therapeutics Market sizing
Non-Cancerous Skin Diseases Therapeutics Market forecast
Non-Cancerous Skin Diseases Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-cancerous skin diseases therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Galderma SA, GlaxoSmithKline PLC, Incyte Corp., LEO Pharma AS, Merck KGaA, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., UCB SA, Viatris Inc., and XBiotech Inc.. Also, the non-cancerous skin diseases therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Therapy Area
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Non-Cancerous Skin Diseases Therapeutics Market 2019 - 2023
Historic Market Size - Data Table on Global Non-Cancerous Skin Diseases Therapeutics Market 2019 - 2023 ($ million)
5.2 Therapy Area segment analysis 2019 - 2023
Historic Market Size - Therapy Area Segment 2019 - 2023 ($ million)
5.3 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI in global non-cancerous skin diseases therapeutics market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Therapy Area
8.1 Market segments
Chart on Therapy Area - Market share 2024-2029 (%)
Data Table on Therapy Area - Market share 2024-2029 (%)
8.2 Comparison by Therapy Area
Chart on Comparison by Therapy Area
Data Table on Comparison by Therapy Area
8.3 Psoriasis - Market size and forecast 2024-2029
Chart on Psoriasis - Market size and forecast 2024-2029 ($ million)
Data Table on Psoriasis - Market size and forecast 2024-2029 ($ million)
Chart on Psoriasis - Year-over-year growth 2024-2029 (%)
Data Table on Psoriasis - Year-over-year growth 2024-2029 (%)
8.4 Eczema - Market size and forecast 2024-2029
Chart on Eczema - Market size and forecast 2024-2029 ($ million)
Data Table on Eczema - Market size and forecast 2024-2029 ($ million)
Chart on Eczema - Year-over-year growth 2024-2029 (%)
Data Table on Eczema - Year-over-year growth 2024-2029 (%)
8.5 Acne vulgaris - Market size and forecast 2024-2029
Chart on Acne vulgaris - Market size and forecast 2024-2029 ($ million)
Data Table on Acne vulgaris - Market size and forecast 2024-2029 ($ million)
Chart on Acne vulgaris - Year-over-year growth 2024-2029 (%)
Data Table on Acne vulgaris - Year-over-year growth 2024-2029 (%)
8.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Therapy Area
Market opportunity by Therapy Area ($ million)
Data Table on Market opportunity by Therapy Area ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
9.3 Injectable - Market size and forecast 2024-2029
Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Chart on Injectable - Year-over-year growth 2024-2029 (%)
Data Table on Injectable - Year-over-year growth 2024-2029 (%)
9.4 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
9.5 Topical - Market size and forecast 2024-2029
Chart on Topical - Market size and forecast 2024-2029 ($ million)
Data Table on Topical - Market size and forecast 2024-2029 ($ million)
Chart on Topical - Year-over-year growth 2024-2029 (%)
Data Table on Topical - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by End-user
10.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
10.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
10.4 Dermatology clinics - Market size and forecast 2024-2029
Chart on Dermatology clinics - Market size and forecast 2024-2029 ($ million)
Data Table on Dermatology clinics - Market size and forecast 2024-2029 ($ million)
Chart on Dermatology clinics - Year-over-year growth 2024-2029 (%)
Data Table on Dermatology clinics - Year-over-year growth 2024-2029 (%)
10.5 Homecare - Market size and forecast 2024-2029
Chart on Homecare - Market size and forecast 2024-2029 ($ million)
Data Table on Homecare - Market size and forecast 2024-2029 ($ million)
Chart on Homecare - Year-over-year growth 2024-2029 (%)
Data Table on Homecare - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.12 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.13 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.14 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.15 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.16 South Africa - Market size and forecast 2024-2029
Chart on South Africa - Market size and forecast 2024-2029 ($ million)
Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
Chart on South Africa - Year-over-year growth 2024-2029 (%)
Data Table on South Africa - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
15.5 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
SWOT
15.6 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
15.7 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
SWOT
15.8 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
15.9 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key offerings
SWOT
15.10 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
15.11 Galderma SA
Galderma SA - Overview
Galderma SA - Product / Service
Galderma SA - Key offerings
SWOT
15.12 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
SWOT
15.13 LEO Pharma AS
LEO Pharma AS - Overview
LEO Pharma AS - Product / Service
LEO Pharma AS - Key offerings
SWOT
15.14 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
SWOT
15.15 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.16 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.17 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15.18 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
16.6 Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations